UniProt ID | PLK1_HUMAN | |
---|---|---|
UniProt AC | P53350 | |
Protein Name | Serine/threonine-protein kinase PLK1 | |
Gene Name | PLK1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 603 | |
Subcellular Localization | Nucleus. Chromosome, centromere, kinetochore. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, spindle . Midbody. localization at the centrosome starts at the G1/S transition (PubMed:24018379). During earl | |
Protein Description | Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, CENPU, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGO1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1, WEE1 and HNRNPU. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, CENPU, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, CENPU, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatid cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGO1: required for spindle pole localization of isoform 3 of SGO1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis. Phosphorylates MISP, leading to stabilization of cortical and astral microtubule attachments required for proper spindle positioning. [PubMed: 8991084] | |
Protein Sequence | MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEEPVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSAAVTAGK ------CCCCHHHHH | 25.57 | 22814378 | |
2 | Phosphorylation | ------MSAAVTAGK ------CCCCHHHHH | 25.57 | 20068231 | |
6 | Phosphorylation | --MSAAVTAGKLARA --CCCCHHHHHHHCC | 25.60 | 17192257 | |
9 | Acetylation | SAAVTAGKLARAPAD CCCHHHHHHHCCCCC | 36.19 | 23954790 | |
9 | Ubiquitination | SAAVTAGKLARAPAD CCCHHHHHHHCCCCC | 36.19 | 24816145 | |
19 | Acetylation | RAPADPGKAGVPGVA CCCCCCCCCCCCCCC | 47.56 | 26051181 | |
19 | Ubiquitination | RAPADPGKAGVPGVA CCCCCCCCCCCCCCC | 47.56 | 33845483 | |
38 | Ubiquitination | PAAAPPAKEIPEVLV CCCCCCHHHCCCEEC | 63.05 | 21906983 | |
49 | Phosphorylation | EVLVDPRSRRRYVRG CEECCCCHHCHHCCC | 35.21 | 22817900 | |
61 | Acetylation | VRGRFLGKGGFAKCF CCCCCCCCCCCCCEE | 58.99 | 25953088 | |
61 | Ubiquitination | VRGRFLGKGGFAKCF CCCCCCCCCCCCCEE | 58.99 | 27667366 | |
66 | Ubiquitination | LGKGGFAKCFEISDA CCCCCCCCEEEECCC | 36.88 | 29967540 | |
71 | Phosphorylation | FAKCFEISDADTKEV CCCEEEECCCCCCHH | 21.39 | 29396449 | |
75 | Phosphorylation | FEISDADTKEVFAGK EEECCCCCCHHHCCC | 30.72 | 29396449 | |
76 | Ubiquitination | EISDADTKEVFAGKI EECCCCCCHHHCCCC | 53.05 | 29967540 | |
82 | Ubiquitination | TKEVFAGKIVPKSLL CCHHHCCCCCCHHHH | 36.78 | 33845483 | |
86 | Ubiquitination | FAGKIVPKSLLLKPH HCCCCCCHHHHCCHH | 42.73 | 29967540 | |
91 | Ubiquitination | VPKSLLLKPHQREKM CCHHHHCCHHHHHCH | 40.18 | 32015554 | |
97 | Acetylation | LKPHQREKMSMEISI CCHHHHHCHHEEEEH | 38.16 | 25953088 | |
99 | Phosphorylation | PHQREKMSMEISIHR HHHHHCHHEEEEHHH | 25.08 | 20860994 | |
103 | Phosphorylation | EKMSMEISIHRSLAH HCHHEEEEHHHHHHH | 10.07 | 17192257 | |
137 | Phosphorylation | LELCRRRSLLELHKR HHHHHHHHHHHHHHH | 35.18 | 19804365 | |
143 | Ubiquitination | RSLLELHKRRKALTE HHHHHHHHHHHHCCC | 67.53 | - | |
146 | Ubiquitination | LELHKRRKALTEPEA HHHHHHHHHCCCHHH | 52.35 | - | |
178 | Ubiquitination | RVIHRDLKLGNLFLN CEECCCCCCCCEECC | 59.65 | - | |
200 | Ubiquitination | GDFGLATKVEYDGER CCCCEEEEEEECCCC | 27.71 | 21906983 | |
209 | Ubiquitination | EYDGERKKTLCGTPN EECCCCCCEECCCCC | 53.61 | 29967540 | |
210 | Phosphorylation | YDGERKKTLCGTPNY ECCCCCCEECCCCCC | 30.25 | 23927012 | |
214 | Phosphorylation | RKKTLCGTPNYIAPE CCCEECCCCCCCCHH | 13.83 | 23401153 | |
217 | Phosphorylation | TLCGTPNYIAPEVLS EECCCCCCCCHHHHH | 10.32 | 21945579 | |
224 | Phosphorylation | YIAPEVLSKKGHSFE CCCHHHHHCCCCCCE | 37.18 | 21945579 | |
225 | Ubiquitination | IAPEVLSKKGHSFEV CCHHHHHCCCCCCEE | 59.62 | 29967540 | |
226 | Ubiquitination | APEVLSKKGHSFEVD CHHHHHCCCCCCEEE | 59.48 | - | |
265 | Ubiquitination | ETYLRIKKNEYSIPK HHHHHHHCCCCCCCC | 53.27 | 29967540 | |
268 | Phosphorylation | LRIKKNEYSIPKHIN HHHHCCCCCCCCCCC | 22.69 | 20068231 | |
269 | Phosphorylation | RIKKNEYSIPKHINP HHHCCCCCCCCCCCH | 26.66 | 29970186 | |
272 | Ubiquitination | KNEYSIPKHINPVAA CCCCCCCCCCCHHHH | 56.28 | 23000965 | |
309 | Phosphorylation | DEFFTSGYIPARLPI CCCCCCCCCCCCCCE | 11.96 | 27642862 | |
326 | Phosphorylation | LTIPPRFSIAPSSLD EECCCCCCCCCCCCC | 21.08 | 25850435 | |
330 | Phosphorylation | PRFSIAPSSLDPSNR CCCCCCCCCCCCCCC | 34.21 | 23663014 | |
331 | Phosphorylation | RFSIAPSSLDPSNRK CCCCCCCCCCCCCCC | 35.41 | 25159151 | |
335 | Phosphorylation | APSSLDPSNRKPLTV CCCCCCCCCCCCCCH | 49.27 | 29396449 | |
338 | Ubiquitination | SLDPSNRKPLTVLNK CCCCCCCCCCCHHCC | 48.94 | 21963094 | |
338 | Sumoylation | SLDPSNRKPLTVLNK CCCCCCCCCCCHHCC | 48.94 | 28112733 | |
341 | Phosphorylation | PSNRKPLTVLNKGLE CCCCCCCCHHCCCCC | 31.32 | 27470641 | |
345 | Ubiquitination | KPLTVLNKGLENPLP CCCCHHCCCCCCCCC | 61.79 | 29967540 | |
358 | Ubiquitination | LPERPREKEEPVVRE CCCCCCCCCCCCCCC | 69.52 | 29901268 | |
366 | Phosphorylation | EEPVVRETGEVVDCH CCCCCCCCCCEEEEC | 28.25 | 21712546 | |
375 | Phosphorylation | EVVDCHLSDMLQQLH CEEEECHHHHHHHHH | 9.41 | 17192257 | |
383 | Phosphorylation | DMLQQLHSVNASKPS HHHHHHHHCCCCCHH | 26.17 | 25159151 | |
387 | Phosphorylation | QLHSVNASKPSERGL HHHHCCCCCHHHCCC | 39.64 | 18669648 | |
388 | Ubiquitination | LHSVNASKPSERGLV HHHCCCCCHHHCCCC | 50.59 | 29967540 | |
413 | Ubiquitination | IPIFWVSKWVDYSDK EEEEEEECCCCCHHH | 41.43 | 29967540 | |
425 | Phosphorylation | SDKYGLGYQLCDNSV HHHCCCCCCCCCCCE | 11.89 | - | |
445 | Phosphorylation | DSTRLILYNDGDSLQ CCCEEEEECCCCCEE | 12.29 | - | |
450 | Phosphorylation | ILYNDGDSLQYIERD EEECCCCCEEEEEEC | 23.93 | 25159151 | |
459 | Phosphorylation | QYIERDGTESYLTVS EEEEECCCCEEEEEC | 26.50 | - | |
461 | Phosphorylation | IERDGTESYLTVSSH EEECCCCEEEEECCC | 25.86 | 17192257 | |
462 | Phosphorylation | ERDGTESYLTVSSHP EECCCCEEEEECCCC | 10.52 | - | |
464 | Phosphorylation | DGTESYLTVSSHPNS CCCCEEEEECCCCCC | 15.31 | 17192257 | |
466 | Phosphorylation | TESYLTVSSHPNSLM CCEEEEECCCCCCHH | 20.07 | 30631047 | |
467 | Phosphorylation | ESYLTVSSHPNSLMK CEEEEECCCCCCHHH | 38.33 | 28555341 | |
474 | Acetylation | SHPNSLMKKITLLKY CCCCCHHHHHHHHHH | 46.44 | 23236377 | |
474 | Ubiquitination | SHPNSLMKKITLLKY CCCCCHHHHHHHHHH | 46.44 | 23000965 | |
475 | Ubiquitination | HPNSLMKKITLLKYF CCCCHHHHHHHHHHH | 27.27 | 23000965 | |
480 | Ubiquitination | MKKITLLKYFRNYMS HHHHHHHHHHHHHHH | 45.51 | 23000965 | |
492 | Sumoylation | YMSEHLLKAGANITP HHHHHHHHCCCCCCC | 51.65 | - | |
492 | Ubiquitination | YMSEHLLKAGANITP HHHHHHHHCCCCCCC | 51.65 | 23000965 | |
498 | Phosphorylation | LKAGANITPREGDEL HHCCCCCCCCCCCHH | 18.99 | 17307877 | |
561 | Phosphorylation | DEKRDFRTYRLSLLE CCCCCCHHHHHHHHH | 17.00 | 22199227 | |
562 | Phosphorylation | EKRDFRTYRLSLLEE CCCCCHHHHHHHHHH | 12.80 | 22199227 | |
565 | Phosphorylation | DFRTYRLSLLEEYGC CCHHHHHHHHHHHCH | 23.16 | 21815630 | |
574 | Ubiquitination | LEEYGCCKELASRLR HHHHCHHHHHHHHHH | 60.89 | 33845483 | |
578 | Phosphorylation | GCCKELASRLRYART CHHHHHHHHHHHHHH | 44.46 | - | |
582 | Phosphorylation | ELASRLRYARTMVDK HHHHHHHHHHHHHHH | 12.67 | 24719451 | |
589 | Ubiquitination | YARTMVDKLLSSRSA HHHHHHHHHHHCCCH | 39.66 | 23000965 | |
589 | Acetylation | YARTMVDKLLSSRSA HHHHHHHHHHHCCCH | 39.66 | 25953088 | |
592 | Phosphorylation | TMVDKLLSSRSASNR HHHHHHHHCCCHHHH | 33.86 | 24719451 | |
593 | Phosphorylation | MVDKLLSSRSASNRL HHHHHHHCCCHHHHH | 30.17 | 24719451 | |
597 | Phosphorylation | LLSSRSASNRLKAS- HHHCCCHHHHHCCC- | 24.59 | 22202082 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
49 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
137 | S | Phosphorylation | Kinase | MAP3K8 | P41279 | GPS |
137 | S | Phosphorylation | Kinase | PLK2 | Q9NYY3 | PSP |
210 | T | Phosphorylation | Kinase | AURA | O14965 | PSP |
210 | T | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
210 | T | Phosphorylation | Kinase | MAP3K8 | P41279 | GPS |
210 | T | Phosphorylation | Kinase | STK10 | O94804 | PhosphoELM |
217 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
326 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
383 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
425 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
445 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:21700221 |
- | K | Ubiquitination | E3 ubiquitin ligase | KLHL22 | Q53GT1 | PMID:23455478 |
- | K | Ubiquitination | E3 ubiquitin ligase | CHFR | Q96EP1 | PMID:11807090 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLK1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-103; THR-210;THR-214; SER-375; SER-450; SER-461; THR-464 AND THR-498, AND MASSSPECTROMETRY. | |
"Identification of phosphorylation sites in the polo-like kinases Plx1and Plk1 by a novel strategy based on element and electrospray highresolution mass spectrometry."; Wind M., Kelm O., Nigg E.A., Lehmann W.D.; Proteomics 2:1516-1523(2002). Cited for: PHOSPHORYLATION AT SER-335. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210 AND THR-214, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210 AND THR-214, ANDMASS SPECTROMETRY. | |
"Polo-like kinase-1 is activated by aurora A to promote checkpointrecovery."; Macurek L., Lindqvist A., Lim D., Lampson M.A., Klompmaker R.,Freire R., Clouin C., Taylor S.S., Yaffe M.B., Medema R.H.; Nature 455:119-123(2008). Cited for: FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-210 BY AURKA,SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-82; SER-137; ASP-176 ANDTHR-210. | |
"Myosin phosphatase-targeting subunit 1 regulates mitosis byantagonizing polo-like kinase 1."; Yamashiro S., Yamakita Y., Totsukawa G., Goto H., Kaibuchi K., Ito M.,Hartshorne D.J., Matsumura F.; Dev. Cell 14:787-797(2008). Cited for: FUNCTION IN PHOSPHORYLATION OF PPP1R12A, PHOSPHORYLATION AT THR-210,DEPHOSPHORYLATION BY PPP1C, SUBCELLULAR LOCATION, AND MUTAGENESIS OFHIS-538 AND LYS-540. | |
"Phosphorylation of threonine 210 and the role of serine 137 in theregulation of mammalian polo-like kinase."; Jang Y.-J., Ma S., Terada Y., Erikson R.L.; J. Biol. Chem. 277:44115-44120(2002). Cited for: FUNCTION, PHOSPHORYLATION AT SER-137 AND THR-210, AND MUTAGENESIS OFLYS-82; SER-137 AND THR-210. |